Actualización normativa

En un entorno en constante cambio como el sistema de salud, es fundamental mantenerse al día con las nuevas normativas que afectan tanto a profesionales como a pacientes. En este espacio encontrará las leyes, decretos, resoluciones y acuerdos relacionados con el sistema de salud dinámico y en evolución.

También encontrará resúmenes, análisis y todo lo relacionado con la más reciente normatividad, para comprender el posible impacto de los cambios hacia los diferentes actores del sistema.

Ordenar por

Prof. Rory McCrimmon: What is impaired hypoglycaemia awareness?

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.^1,2

Prof. Rory McCrimmon: Why is Nocturnal Hypoglycaemia Important?

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.^1,2

Module 4: An update on RACGP guidelines - Diabetes and Cardiovascular Disease

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

Module 3: An update on RACGP guidelines - Microvascular Complications

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

IL-4-and-IL-13

Module 2: An update on RACGP guidelines - Type 2 Diabetes - Special Populations

Type 2 Inflammation in Asthma

IL-4 and IL-13 are key and central drivers of type 2 inflammation1-3

Module 1: An update on RACGP guidelines - Refreshing Key Concepts of Type 2 Diabetes

The updated RACGP guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence.

Prof. Rory McCrimmon: Patients at Risk of Hypoglycaemia

Hypoglycaemia is a common and serious complication of diabetes, particularly affecting your patients on insulin therapy. It can have serious acute and long-term impacts.^1,2

Type 2 inflammation in CRSwNP

About Fabry Disease

Sophie, Australia. Fabry Disease. (Image used with permission.)

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

MAT-CO-2400825 V1.0 03/2024

Page menu

Actualización normativa

Prof. Rory McCrimmon: What is impaired hypoglycaemia awareness?

Prof. Rory McCrimmon: Why is Nocturnal Hypoglycaemia Important?

Module 4: An update on RACGP guidelines - Diabetes and Cardiovascular Disease

Module 3: An update on RACGP guidelines - Microvascular Complications

IL-4-and-IL-13

Module 2: An update on RACGP guidelines - Type 2 Diabetes - Special Populations

Type 2 Inflammation in Asthma

IL-4 and IL-13 are key and central drivers of type 2 inflammation1-3

Module 1: An update on RACGP guidelines - Refreshing Key Concepts of Type 2 Diabetes

Prof. Rory McCrimmon: Patients at Risk of Hypoglycaemia

Type 2 inflammation in CRSwNP

About Fabry Disease